All Articles

Understanding the Needs of the Adolescent and Young Adult Cancer Population

Implementing the 4Ms (what Matters, Mobility, Mentation, and Medication) will improve your ability to provide age-friendly care. Here’s how.

Adolescents and Young Adults

Navigation as a Catalyst to Reignite Cancer Screenings

Help your AYA patients reach the important milestones in their lives by mitigating long-term impacts of cancer and its treatment.

COVID-19

Navigating the Metastatic Patient

With concerted efforts by navigators, we can increase preventive screening rates.

Metastatic Disease

Best Practices in GU Navigation

The “incurable but treatable” population is growing – here’s how you can best address their unique needs.

Advanced Care Practitioners Take a Lead in Improving Quality of Life and Patient Satisfaction for Cancer Patients

Interview with the Innovators

Video Library

Maintaining quality of life for cancer patients means different things to different cancer patients. However, the conversation starts with helping patients manage their expectations regarding their therapy and how it will impact their quality of life. Please join Laura Wood, RN, MSN, OCN, Megan Price, MSN, APRN, FNP-C, and Virginia Seery, MSN, RN, ANP-BC, AOCNP, as they examine the many ways that they collaborate with their oncology team colleagues to assess and review how an individual patient’s treatment regimen is influencing that patient’s quality of life.

2021 Midyear Review: Non–Small-Cell Lung Cancer

Special Issues and Supplements

Researchers Release Chemo-Immunotherapy Treatment Outcomes Results in Patients with KRAS-Mutant NSCLC Subtypes

NSAID Use with Immune Checkpoint Inhibitors Associated with Longer Overall Survival in NSCLC

Recently released study results report similar chemo-immunotherapy outcomes in KRAS-mutant NSCLC subtypes and poor results in patients with concurrent STK11 and/or KEAP1 mutations.

CodeBreaK 100 Trial Results Demonstrate Sotorasib Conveys Clinical Benefit Across NSCLC Patient Subgroups

A recently released retrospective study demonstrates that NSAID use in patients with NSCLC enhances immune checkpoint efficacy.

Incidental Lung Nodule Program Identifies Early-Stage Lung Cancer More Frequently Than Most LDCT Screening Programs

Subgroup analysis of CodeBreaK 100 trial results found that sotorasib achieved a response in pretreated patients with KRAS^G12C-mutated NSCLC subtypes.